Estrogen-Dependent Cyclin E-cdk2 Activation through p21 Redistribution

REFERENCES

• Adnane, J., P. Gaudray, M.-P. Simon, J. Simony-Lafontaine, P. Jeanteur, and C. Theillet. 1989. Proto-oncogene amplification and human breast cancer tumor phenotype. Oncogene 4:1389–1395.
   PubMed Web of Science ®Google Scholar
• Altucci, L., R. Addeo, L. Cicatiello, S. Dauvois, M. G. Parker, M. Truss, M. Beato, V. Sica, F. Bresciani, and A. Weisz. 1996. 17β-Estradiol induces cyclin D1 gene transcription, p36D2p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G1-arrested human breast cancer cells. Oncogene 12:2315–2324.
   PubMed Web of Science ®Google Scholar
• Bartkova, J., J. Lukas, H. Müller, D. Lützhoft, M. Strauss, and J. Bartek. 1994. Cyclin D1 protein expression and function in human breast cancer. Int. J. Cancer 57:353–361.
   PubMed Web of Science ®Google Scholar
• Bonapace, I. M., R. Addeo, L. Altucci, L. Cicatiello, M. Bifulco, C. Laezza, S. Salzano, V. Sica, F. Bresciani, and A. Weisz. 1996. 17β-Estradiol overcomes a G1 block induced by HMG-CoA reductase inhibitors and fosters cell cycle progression without inducing ERK-1 and -2 MAP kinases activation. Oncogene 12:753–763.
   PubMedGoogle Scholar
• Borg, A., H. Sigurdsson, G. M. Clark, M. Ferno, S. A. Fuqua, H. Olsson, D. Killander, and W. L. McGurie. 1991. Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis. Br. J. Cancer 63:136–142.
   PubMed Web of Science ®Google Scholar
• Buchkovich, K., L. A. Duffy, and E. Harlow. 1989. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58:1097–1105.
   PubMed Web of Science ®Google Scholar
• Buckley, M. F., K. J. E. Sweeney, J. A. Hamilton, R. L. Sini, D. L. Manning, R. I. Nicholson, A. deFazio, C. K. W. Watts, E. A. Musgrove, and R. L. Sutherland. 1993. Expression and amplification of cyclin genes in human breast cancer. Oncogene 8:2127–2133.
   PubMed Web of Science ®Google Scholar
• Clarke, R., R. B. Dickson, and M. E. Lippman. 1992. Hormonal aspects of breast cancer growth factors, drugs and stromal interactions. Crit. Rev. Oncol. Hematol. 12:1–23.
   PubMed Web of Science ®Google Scholar
• DeCaprio, J. A., J. W. Ludlow, D. Lynch, Y. Furukawa, J. Griffin, H. Piwnica-Worms, C.-M. Huang, and D. M. Livingston. 1989. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58:1085–1095.
   PubMed Web of Science ®Google Scholar
• Dubik, D., T. C. Dembinski, and R. P. C. Shiu. 1987. Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells. Cancer Res. 47:6517–6521.
   PubMed Web of Science ®Google Scholar
• Ewen, M. E., H. K. Sluss, L. L. Whitehouse, and D. M. Livingston. 1993. TGF beta inhibition of cdk4 synthesis is linked to cell cycle arrest. Cell 74:1009–1020.
   PubMed Web of Science ®Google Scholar
• Fantl, V., G. Stamp, A. Andrews, I. Rosewell, and C. Dickson. 1995. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev. 9:2364–2372.
   PubMed Web of Science ®Google Scholar
• Foster, J. S., and J. Wimalasena. 1996. Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells. Mol. Endocrinol. 10:488–498.
   PubMedGoogle Scholar
• Geng, Y., and R. A. Weinberg. 1993. Transforming growth factor β effects on expression of G1 cyclins and cyclin-dependent protein kinases. Proc. Natl. Acad. Sci. USA 90:10315–10319.
   PubMed Web of Science ®Google Scholar
• Gorospe, M., Y. Liu, Q. Xu, F. J. Chrest, and N. J. Holbrook. 1996. Inhibition of G1 cyclin-dependent kinase activity during growth arrest of human breast carcinoma cells by prostaglandin A2. Mol. Cell. Biol. 16:762–770.
   PubMed Web of Science ®Google Scholar
• Hannon, G. J., and D. Beach. 1994. p15 INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371:257–261.
   PubMed Web of Science ®Google Scholar
• Harper, J. W., S. J. Elledge, K. Keyomarsi, B. Dynlacht, L.-H. Tsai, P. Zhang, S. Dobrowolski, C. Bai, L. Connell-Crowley, E. Swindell, M. P. Fox, and N. Wei. 1995. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell 6:387–400.
   PubMed Web of Science ®Google Scholar
• Hatakeyama, M., J. A. Brill, G. R. Fink, and R. A. Weinberg. 1994. Collaboration of G1 cyclins in the functional inactivation of the retinoblastoma protein. Genes Dev. 8:1759–1771.
   PubMed Web of Science ®Google Scholar
• Hinds, P. W., S. Mittnacht, V. Dulic, A. Arnold, S. I. Reed, and R. A. Weinberg. 1992. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70:993–1006.
   PubMed Web of Science ®Google Scholar
• Jordan, V. C. 1995. Studies on the estrogen receptor in breast cancer—20 years as a target for the treatment and prevention of cancer. Breast Cancer Res. Treat. 36:267–285.
   PubMed Web of Science ®Google Scholar
• Kato, J., H. Matsushime, S. W. Hiebert, M. F. Ewen, and C. J. Sherr. 1993. Direct binding of cyclin D to the retinoblastoma gene product (pRb) phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 7:331–342.
   PubMed Web of Science ®Google Scholar
• Keyomarsi, K., D. J. Conte, W. Toyofuku, and M. P. Fox. 1995. Deregulation of cyclin E in breast cancer. Oncogene 11:941–950.
   PubMed Web of Science ®Google Scholar
• Keyomarsi, K., N. O’Leary, G. Molnar, E. Lees, H. J. Fingert, and A. B. Pardee. 1994. Cyclin E, a potential prognostic marker for breast cancer. Cancer Res. 54:380–385.
   PubMed Web of Science ®Google Scholar
• Keyomarsi, K., and A. B. Pardee. 1993. Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc. Natl. Acad. Sci. USA 90:1112–1116.
   PubMed Web of Science ®Google Scholar
• Laiho, M., J. A. DeCaprio, J. W. Ludlow, D. M. Livingston, and J. Massague. 1990. Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell 62:175–185.
   PubMed Web of Science ®Google Scholar
• Lammie, G. A., V. Fantl, R. Smith, E. Schuuring, S. Brookes, R. Michalides, C. Dickson, A. Arnold, and G. Peters. 1991. D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene 6:439–444.
   PubMed Web of Science ®Google Scholar
• Latham, K. M., S. W. Eastman, A. Wong, and P. W. Hinds. 1996. Inhibition of p53-mediated growth arrest by overexpression of cyclin-dependent kinases. Mol. Cell. Biol. 16:4445–4455.
   PubMedGoogle Scholar
• Lin, J., C. Reichner, X. Wu, and A. J. Levine. 1996. Analysis of wild-type and mutant p21WAF-I gene activities. Mol. Cell. Biol. 16:1786–1793.
   PubMed Web of Science ®Google Scholar
• Matsushime, H., M. F. Roussel, R. A. Ashum, and C. J. Sherr. 1991. Colonystimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 65:701–713.
   PubMed Web of Science ®Google Scholar
• Morgan, D. O. 1995. Principles of CDK regulation. Nature 374:131–134.
   PubMed Web of Science ®Google Scholar
• Musgrove, E., R. Lilischkis, A. L. Cornish, S. L. Lee, V. Setlur, and R. Seshadri. 1995. Expression of the cyclin dependent kinase inhibitors p16INK4, p15INK4B and p21WAF1/CIP1 in human breast cancer. Int. J. Cancer 63:584–591.
   PubMed Web of Science ®Google Scholar
• Musgrove, E. A., J. A. Hamilton, C. S. L. Lee, K. J. E. Sweeney, C. K. W. Watts, and R. L. Sutherland. 1993. Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. Mol. Cell. Biol. 13:3577–3587.
   PubMed Web of Science ®Google Scholar
• Musgrove, E. A., C. S. Lee, M. F. Buckley, and R. L. Sutherland. 1994. Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle. Proc. Natl. Acad. Sci. USA 91:8022–8026.
   PubMed Web of Science ®Google Scholar
• Musgrove, E. A., B. Sarcevic, and R. L. Sutherland. 1996. Inducible expression of cyclin D1 in T-47D human breast cancer cells is sufficient for cdk2 activation and pRB hyperphosphorylation. J. Cell. Biochem. 60:363–378.
   PubMed Web of Science ®Google Scholar
• Musgrove, E. A., A. E. Wakeling, and R. L. Sutherland. 1989. Points of action of estrogen antagonists and a calmodulin antagonist within the MCF-7 human breast cancer cell cycle. Cancer Res. 49:2398–2404.
   PubMedGoogle Scholar
• Osborne, C. K., D. H. Bodl, G. M. Clark, and J. M. Trent. 1983. Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase. Cancer Res. 43:3583–3585.
   PubMed Web of Science ®Google Scholar
• Pardee, A. B. 1974. A restriction point for control of normal animal cell proliferation. Proc. Natl. Acad. Sci. USA 71:1286–1290.
   PubMed Web of Science ®Google Scholar
• Pardee, A. B. 1989. G1 events and regulation of cell proliferation. Science 246:603–608.
   PubMed Web of Science ®Google Scholar
• Peters, G., V. Fantl, R. Smith, S. Brookes, and C. Dickson. 1995. Chromosome 11q13 markers and D-type cyclins in breast cancer. Breast Cancer Res. Treat. 33:125–135.
   PubMed Web of Science ®Google Scholar
• Planas-Silva, M. D., and R. A. Weinberg. Unpublished data.
   Google Scholar
• Poon, R. Y. C., H. Toyoshima, and T. Hunter. 1995. Redistribution of the CDK inhibitor p27 between different cyclin-CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation. Mol. Biol. Cell 6:1197–1213.
   PubMed Web of Science ®Google Scholar
• Resnitzky, D., and S. I. Reed. 1995. Different roles for cyclins D1 and E in regulation of the G1-to-S transition. Mol. Cell. Biol. 15:3463–3469.
   PubMed Web of Science ®Google Scholar
• Reynisdóttir, I., K. Polyak, A. Lavarone, and J. Massagué. 1995. Kip/Cip and Ink4 cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev. 83:1831–1845.
   Google Scholar
• Schuuring, E., E. Verhoeven, H. van Tinteren, J. L. Peterse, B. Nunnink, F. B. Thunnissen, P. Devilee, C. J. Cornelisse, M. J. van de Vijver, W. J. Mooi, and R. J. A. M. Michaelides. 1992. Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. Cancer Res. 52:5229–5234.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J. 1994. G1 phase progression: cycling on cue. Cell 79:551–555.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J., and J. M. Roberts. 1995. Inhibitors of mammalian G1 cyclin- dependent kinases. Genes Dev. 9:1149–1163.
   PubMed Web of Science ®Google Scholar
• Sicinski, P., J. Liu-Donaher, S. B. Parker, T. Li, A. Fazeli, H. Gardner, S. Z. Haslam, R. T. Bronson, S. J. Elledge, and R. A. Weinberg. 1995. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82:621–630.
   PubMed Web of Science ®Google Scholar
• Soos, T. J., H. Kiyokawa, J. Yan, S., M. S. Rubin, A. Giordano, A. DeBlasio, S. Bottega, B. Wong, J. Mendelsohn, and A. Koff. 1996. Formation of p27- cdk complexes during the human mitotic cell cycle. Cell Growth Differ. 7:135–146.
   PubMedGoogle Scholar
• Sutherland, R. L., M. D. Green, R. E. Hall, R. R. Reddel, and I. W. Taylor. 1983. Tamoxifen induces accumulation of MCF7 human mammary carcinoma cells in the G0/G1 phase of the cell cycle. Eur. J. Cancer Clin. Oncol. 19:615–621.
   PubMedGoogle Scholar
• Taylor, I. W., P. J. Hoodson, M. D. Green, and R. L. Sutherland. 1983. Effects of tamoxifen on cell cycle progression of synchronous MCF-7 human mammary carcinoma cells. Cancer Res. 43:4007–4010.
   PubMedGoogle Scholar
• Wang, T. C., R. D. Cardiff, L. Zukerberg, E. Lees, A. Arnold, and E. V. Schmidt. 1994. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369:669–671.
   PubMed Web of Science ®Google Scholar
• Watts, C. K. W., A. Brady, B. Sarcevic, A. de Fazio, E. A. Musgrove, and R. L. Sutherland. 1995. Antiestrogen inhibition of cell cycle progression in breast cancer cells is associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation. Mol. Endocrinol. 9:1804–1813.
   PubMedGoogle Scholar
• Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323–330.
   PubMed Web of Science ®Google Scholar
• Weinstat-Saslow, D., M. J. Merino, R. E. Manrow, J. A. Lawrence, R. F. Bluth, K. D. Wittenbel, J. F. Simpson, D. L. Page, and P. S. Steeg. 1995. Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nature Med. 1:1257–1260.
   PubMed Web of Science ®Google Scholar
• Zhang, H., G. J. Hannon, and D. Beach. 1994. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev. 8:1750–1758.
   PubMed Web of Science ®Google Scholar
• Zwijsen, R. M. L., R. Klompmaker, E. Wientjens, P. M. P. Kristel, B. van der Burg, and R. J. A. M. Michalides. 1996. Cyclin D1 triggers autonomous growth of breast cancer cells by governing cell cycle exit. Mol. Cell. Biol. 16:2554–2560.
   PubMed Web of Science ®Google Scholar